Skip to main content

Table 6 Pilot study overall survival from randomisation

From: Accrual to a randomised trial of adjuvant whole brain radiotherapy for treatment of melanoma brain metastases is feasible

Months

Percentage surviving

6

68.5

12

50.0

18

35.2

24

31.3